These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38641473)

  • 1. Corrigendum to "MEGF6 prevents sepsis-induced acute lung injury in mice" [Int. Immunopharmacol. 123 (2023) 110727].
    Liang H; Liu G; Zeng W; Fan Q; Nie Z; Hu H; Zhang R; Xie S
    Int Immunopharmacol; 2024 May; 133():111787. PubMed ID: 38641473
    [No Abstract]   [Full Text] [Related]  

  • 2. MEGF6 prevents sepsis-induced acute lung injury in mice.
    Liang H; Liu G; Zeng W; Fan Q; Nie Z; Hu H; Zhang R; Xie S
    Int Immunopharmacol; 2023 Oct; 123():110727. PubMed ID: 37597402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats" [Int. Immunopharmacol. 72 (2019) 211-217].
    Xia W; Zhang H; Pan Z; Li G; Zhou Q; Hu D; Liu Y
    Int Immunopharmacol; 2023 Sep; 122():110699. PubMed ID: 37500384
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Exosomal miR-127-5p from BMSCs alleviated sepsis-related acute lung injury by inhibiting neutrophil extracellular trap formation" [Int. Immunopharmacol. 123 (2023) 110759].
    Zheng XL; Gu WJ; Zhang F; Zhao FZ; Li LZ; Huang HY; Li LJ; Yi YH; Yin HY; Xu J
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111076. PubMed ID: 37866976
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Gypenoside XLIX attenuates sepsis-induced splenic injury through inhibiting inflammation and oxidative stress" [Int. Immunopharmacol. 127 (2024) 111420].
    Xu B; Yang R; Qiang J; Xu X; Zhou M; Ji X; Lu Y; Dong Z
    Int Immunopharmacol; 2024 Apr; 131():111694. PubMed ID: 38368241
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "MicroRNA-208-5p regulates myocardial injury of sepsis mice via targeting SOCS2-mediated NF-κB/HIF-1α pathway" [Int. Immunopharmacol. 81 (2020) 106204].
    Ouyang H; Tan Y; Li Q; Xia F; Xiao X; Zheng S; Lu J; Zhong J; Hu Y
    Int Immunopharmacol; 2022 Mar; 104():108355. PubMed ID: 35058156
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Maclurin inhibits caspase-11 non-canonical inflammasome in macrophages and ameliorates acute lethal sepsis in mice" [Int. Immunopharmacol. 129 (2024) 111615].
    Lee DJ; Lee SY; Yi YS
    Int Immunopharmacol; 2024 May; 132():111969. PubMed ID: 38575463
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis" [Int. Immunopharmacol. 90 (2021) 107187].
    Wu YX; Zeng S; Wan BB; Wang YY; Sun HX; Liu G; Gao ZQ; Chen D; Chen YQ; Lu MD; Pang QF
    Int Immunopharmacol; 2023 Nov; 124(Pt A):111008. PubMed ID: 37806791
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Neutrophil elastase in dexmedetomidine alleviating sepsis-related renal injury in rats" [Int. Immunopharmacol. 122 (2023) 110441].
    Chen L; Li M; Lin Y; Li Y; Liang M; Zeng K
    Int Immunopharmacol; 2024 Feb; 128():111577. PubMed ID: 38281885
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Curcumin attenuates sepsis-induced acute organ dysfunction by preventing inflammation and enhancing the suppressive function of Tregs" [Int. Immunopharmacol. 61 (2018) 1-7].
    Chen L; Lu Y; Zhao L; Hu L; Qiu Q; Zhang Z; Li M; Hong G; Wu B; Zhao G; Lu Z
    Int Immunopharmacol; 2024 Aug; 137():112471. PubMed ID: 38879417
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "PAD4 selective inhibitor TDFA protects lipopolysaccharide-induced acute lung injury by modulating nuclear p65 localization in epithelial cells" [Int. Immunopharmacol. 88 (2020) 106923].
    Zhao X; Gu C; Wang Y
    Int Immunopharmacol; 2023 Dec; 125(Pt B):111185. PubMed ID: 37957096
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "GTS-21 attenuates ACE/ACE2 ratio and glycocalyx shedding in lipopolysaccharide-induced acute lung injury by targeting macrophage polarization derived ADAM-17" [Int. Immunopharmacol. 129 (2024) 111603].
    Zhu W; Wang F; Hu C; Zhao Q; Zhang D; Wang X; Hu B; Li J
    Int Immunopharmacol; 2024 May; 132():111914. PubMed ID: 38582738
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Emodin attenuates acute lung injury in cecal-ligation and puncture rats" [Int. Immunopharmacol. 85 (2020) 106626].
    Guo R; Li Y; Han M; Liu J; Sun Y
    Int Immunopharmacol; 2023 Sep; 122():110700. PubMed ID: 37507324
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Methylallyl sulfone attenuates inflammation, oxidative stress and lung injury induced by cigarette smoke extract in mice and RAW264.7 cells" Int Immunopharmacol, volume 59, 2018, 369-374.
    Li A; Liu Y; Zhu X; Sun X; Feng X; Li D; Zhang J; Zhu M; Zhao Z
    Int Immunopharmacol; 2019 Jul; 72():522. PubMed ID: 30922802
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol alleviates inflammatory responses in LPS-induced mice liver sepsis through inhibition of STAT3 phosphorylation" [Int. Immunopharmacol. 125(Part B) (2023) 111124].
    Kim B; Yu JE; Yeo IJ; Son DJ; Lee HP; Roh YS; Lim KH; Yun J; Park H; Han SB; Hong JT
    Int Immunopharmacol; 2024 Aug; 137():112543. PubMed ID: 38926074
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Taxifolin ameliorates Benzo[a]pyrene-induced lung injury possibly via stimulating the Nrf2 signalling pathway" [Int. Immunopharmacol. 96 (2021) 107566].
    Islam J; Shree A; Vafa A; Afzal SM; Sultana S
    Int Immunopharmacol; 2023 Jun; 119():110096. PubMed ID: 37095029
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "4-Hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice" [Int. Immunopharmacol. 83 (2020) 106445].
    Wang H; Wei X; Wei X; Sun X; Huang X; Liang Y; Xu W; Zhu X; Lin X; Lin J
    Int Immunopharmacol; 2020 Sep; 86():106722. PubMed ID: 32593975
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Sivelestat ameliorates sepsis-induced myocardial dysfunction by activating the PI3K/AKT/mTOR signaling pathway" [Int. Immunopharmacol. 128 (2024) https://doi.org/10.1016/j.intimp.2023.111466].
    Geng H; Zhang H; Cheng L; Dong S
    Int Immunopharmacol; 2024 Apr; 131():111873. PubMed ID: 38514302
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Maackiain protects against sepsis via activating AMPK/Nrf2/HO-1 pathway" [Int. Immunopharmacol. 108 (2022) 108710].
    Bai X; Zhu Y; Jie J; Li D; Song L; Luo J
    Int Immunopharmacol; 2024 Oct; 140():112877. PubMed ID: 39127491
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Tryptase inhibitor APC 366 prevents hepatic fibrosis by inhibiting collagen synthesis induced by tryptase/protease-activated receptor 2 interactions in hepatic stellate cells" [Int. Immunopharmacol. 20 (2014) 352-357].
    Lu J; Chen B; Li S; Sun Q
    Int Immunopharmacol; 2019 Apr; 69():408. PubMed ID: 30755386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.